Aster DM Healthcare’s Board approved the unaudited financial results for Q2 2026. Key highlights include revenue from operations of ₹1,294.85 crores and a profit of ₹185.20 crores. In other news, Anoop Moopen has resigned from his position as Non-Executive Director due to other business commitments. Also, TJ Wilson was inducted as a member of the Nomination and Remuneration Committee. The board also approved a new registered office in Hyderabad.
Financial Performance Approved
The Board of Directors approved the unaudited standalone financial results for the quarter ended September 30, 2025. Key financial figures include:
- Revenue from operations: ₹1,294.85 crores
- Total Income: ₹1,377.92 crores
- Profit for the period: ₹185.20 crores
The results also included a review by the Audit Committee and an unmodified opinion from the Statutory Auditor.
Director Resignation and Committee Changes
Anoop Moopen has resigned from his position as Non-Executive Director, effective close of business hours on November 6, 2025, due to existing business commitments. Consequently, he also ceases to be a member of various board committees.
New Registered Office in Hyderabad Approved
The board approved a new registered office in Hyderabad, Telangana, subject to regulatory approval. The new address will be: No. 7-1-450/20, Plot No. 04, Mythri Vihar, Ameerpet, Hyderabad, Telangana – 500038. This change is pending approval from the Regional Director.
Employee Stock Option Scheme Update
Consideration of the Employee Stock Option Scheme 2025 (ESOS 2025) was deferred to a later meeting for further review.
Source: BSE
